Goserelin reduces risk of chemo-related early menopause, investigators say
But other specialists urge further research
30th October 2018
By Rada Rouse
YOUNG women undergoing chemotherapy for breast cancer can double their chances of preserving fertility by receiving injections of a gonadotrophin-releasing hormone agonist (GnRHa) at the same time, researchers say.
Five-year results from the international Prevention of Early Menopause Study (POEMS), show that 23% of women receiving the GnRHa goserelin alongside chemotherapy self-reported pregnancy after their treatment, compared with 12% of those who received chemotherapy alone.
In the final analysis, data